ovarian cancer News
Most Popular ovarian cancer Story
GSK: Ovarian cancer drug positive in Phase II
GlaxoSmithKline says it will push pazopanib into late-stage studies for ovarian cancer after a mid-stage trial produced positive data on a key biomarker. Only 35 patients participated in the Phase II... Read more...
Latest Headlines
- September 15, 2008
- May 21, 2008
- January 18, 2008
- October 12, 2007
- August 29, 2007
- July 12, 2007
- January 4, 2007
- November 30, 2006
- November 28, 2006
- January 31, 2006
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
